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Introduction
A wide spectrum of direct or indirect manifestations of human immunodeficiency virus (HIV) in the eye may occur any time during the natural course of the disease.
1 CD4þ T-lymphocyte counts are a reasonable predictor of the risk of ocular complications of HIV infection 2 ; however, the use of anti-retroviral therapy (ART) has allowed a substantial repopulation of T-lymphocytes to occur in many patients.
3, 4 The recovery of CD4þ T-lymphocytes takes months to years and patients have already had long-lasting depletion of CD4þ T-lymphocyte counts. 4, 5 A recent report on cytomegalovirus (CMV) retinitis in patients on ART and with CD4þ cells >200 cells/mL suggests that reconstituted CD4þ cells may fail to provide protective immunity. Alternatively, the onset of CMV retinitis preceded the recovery of CD4þ T-lymphocytes. 6 Hence, the classical school of thought, of correlating most HIV-related ocular lesions with blood CD4þ cell counts might not be reasonable in the present era of ART. Most of the studies on ocular manifestations of HIV are on patients with acquired immunodeficiency syndrome (AIDS)-defining criteria or with low CD4þ counts, and the association of the ocular findings with the CD4þ counts has not been analysed. 7e11 We could not find a study on ocular manifestations in asymptomatic cases detected to be HIV-positive on voluntary screening. Human immunodeficiency virus-positive on voluntary screening. Hence, a cross-sectional study was carried out in which all the cases attending the HIV-referral centre of our hospital between July 2009 and August 2010 were examined with the aim to: a. study the ocular manifestations of HIV; b. correlate the observed manifestations with the CD4þ Tlymphocyte counts; c. compare our findings with the other similar studies.
Materials and method
All patients reporting to the HIV-referral centre at our hospital were subjected to ophthalmic examination. All were serologically confirmed cases of HIV/AIDS. A total of 321 cases (642 eyes) were studied. The cases were classified according to the centres for disease control and prevention (CDC) classification system for HIV/AIDS which is based on the lowest documented CD4þ cell count and on previously diagnosed HIVrelated conditions. A detailed history was followed by ophthalmic examination which included Snellen's visual acuity, ocular motility, visual field by confrontation test, and automated perimetry whenever required. The eyelids, adnexae, and the anterior segment were examined by torchlight and slit lamp biomicroscope. Posterior segment was examined by indirect ophthalmoscopy after my-driasis. Retinal lesions were studied with digital fundus photography with or without fundus fluorescein angiography (FFA). The CD4þ cell counts, haemogram, biochemical profile, venereal disease research laboratory (VDRL) test, Mantoux test, chest radiograph, and ultrasonography of abdomen of all the cases, and serum TORCH titres of relevant cases were done.
The last 125 cases were subjected to the following two tests, which are indicators of dry eye: a. Schirmer's test. The Schirmer's test strip (5 Â 35 mm 2 ) was inserted at the junction of middle and lateral one-third of the inferior fornix of the eye. The wetting of the strip at the end of five minutes was recorded (Fig. 1) . b. Tear film break-up time (TBUT). Fluorescein dye was instilled into the eye (1 mg fluorescein sodium per strip) and the time taken for the appearance of the first random dry spot on the cornea was noted under cobalt blue filtred light of a slit lamp (Fig. 1) . 
A TBUT of < 10 seconds or a wetting of Schirmer's strip of < 15 mm was taken as indicative of dry eye. The findings were statistically analysed to find the association of the ocular lesions both collectively and individually with the CD4þ count levels.
Results
A total of 321 male cases (642 eyes), 23-53 years of age (mean 36.78 years), with CD4þ counts in the range of 6-1,481 cells/mL (mean 276.54 cells/mL) were studied. Out of the total 321 cases, 253 cases (78.82%) were on ART for an average duration of 2.17 years. The average duration of the disease in this study from the date of detection was 34.16 months. The clinical and the CD4þ count based categories of these patients are outlined in Table 1 .
Ocular manifestations excluding dry eye were seen in 87 cases (27.10% of all cases), with many cases out of these 87 having more than one type of lesion. Of these 87 cases, 75 cases (86.21 %) were on ART, and 63 cases (72.41 %) were in the asymptomatic stage A of HIV infection, detected to be HIVpositive on routine voluntary screening. The duration of ART in these 75 cases was two months to nine years (average 2.13 years). The clinical and the CD4þ count based categories of these patients are given in Table 1 . A statistically very significant association was found between the levels of CD4þ counts and the overall occurrence of ocular involvement (P ¼ 0.000019), the maximum prevalence being in the CD4þ range of < 200 cells/mL. There was no significant difference between the occurrence of ocular manifestations in the asymptomatic carriers of HIV and symptomatic HIV patients (P ¼ 0.994).
Six cases (1.87% of 321) with a CD4þ range of 76À345 (mean 216) cells/mL had molluscum contagiosum either on the eyelids or on the periorbital skin ( Fig. 1 ). Of these six cases, three had CD4þ count between 200 cells/mL and 499 cells/mL, and the remaining three had CD4þ count <200 cells/mL; five cases were in clinical stage A, and the remaining one in stage C. The association of this finding with the CD4þ count could not be analysed because of the few number of cases with the lesion.
Conjunctival microvasculopathy, seen as capillary dilatation, isolated vascular fragments, irregular vessel calibre, and a granular appearance of blood column within blood vessels was seen in 31 cases (9.66% of 321) with a CD4þ range of 58-560 (mean 220.74) cells/mL (Fig. 2) . 12, 13 Of these 31 cases, one case (3.23%) had CD4 þ count >500 cells/mL, 15 cases (48.39%) had CD4þ count between 200 cells/mL and 499 cells/mL, and the remaining 15 (48.39%) <200 cells/mL; 27 cases (87.10%) were in clinical stage A and the remaining four (12.9%) in stage C. The association of these findings with the CD4þ count was not significant (P ¼ 0.302).
Signs of healed anterior uveitis in the form of pigmented keratic precipitates/flare in anterior chamber/pigment on anterior capsule of the lens/posterior synechiae or complicated cataract were found in 25 cases (7.79% of 321) with a CD4þ range of 52-576 (mean 232.52) cells/mL (Fig. 3 ). Of these 25 cases, four cases (16%) had CD4þ count >500 cells/mL, another four (16%) between 200 cells/mL and 499 cells/mL, and the remaining 17 cases (68%) <200 cells/mL; 20 cases (76.92%) were in clinical stage A, one (3.85%) in stage B and the remaining four (15.38%) in stage C. There was a statistically significant association between the occurrence of anterior uveitis and the CD4þ counts (P ¼ 0.004).
Human immunodeficiency virus retinopathy in the form of soft exudates or retinal haemorrhages was seen in 12 cases (3.74% of 321) with a CD4þ range of 52À837 (mean 169.83) cells/mL (Fig. 3) . Of these 12 cases, one case (8.33%) had CD4þ count >500 cells/mL, another two (16.67%) between 200 cells/mL and 499 cells/mL, and remaining nine (75%) <200 cells/mL; seven cases (58.33%) were in clinical stage A, and the remaining five (41.67%) in stage C. This finding also had a significant association with the CD4 þ count (P ¼ 0.048).
Eighteen cases (5.6% of 321) with a CD4þ range of 51À269 (mean 156.88) cells/mL had posterior uveitis. Of these 18 cases, four cases (27.78%) had CD4þ count between 200 cells/mL and 499 cells/mL, and remaining 14 cases (72.22%) <200 cells/mL; 11 cases (61.11%) were in clinical stage A, one (5.56%) in stage B and the remaining six (33.33%) in stage C. Of these 18 cases,13 had healed patches of choroiditis or chorioretinitis; one of them with a raised Mantoux test reading of 20 mm and CD4þ count of 269 cells/mL had a healed choroid tuberculoma. However, none of the cases were in the active infective stage needing aggressive management. Three cases had healed retinal vasculitis, one with complicated cataract in both eyes. 
Two cases had CMV retinitis in both eyes (Fig. 4) . Of these two cases, one with a CD4þ count of 54 cells/mL had healed patches of retinitis with complicated cataract in both eyes. The other with a CD4þ count of 51 cells/mL had active CMV retinitis in both eyes with a typical pizza-pie appearance and a complicated cataract in the right eye, and was already on oral valganciclovir. This case had a best corrected distant visual acuity of perception of light in right eye and 20/30 vision in the left eye. None of the cases had immune recovery uveitis (IRU). There was a statistically significant association between the occurrence of posterior uveitis and the CD4þ counts (P ¼ 0.004).
Three cases (0.93% of 321) with a CD4þ range of 22À222 (mean 143.67) cells/mL had neuro-ophthalmic manifestations. One of these had HIV encephalitis and disseminated tuberculosis (TB), with a CD4þ count of 222 cells/mL, and right congruous homonymous hemianopia. Magnetic resonance imaging (MRI) of brain revealed focal lesions in the left occipital cerebral lobe (Fig. 5A) . The second case, had progressive multi-focal leucoencephalopathy and disseminated TB, had a CD4þ count of 187 cells/mL, with multiple bilateral lesions in both temporoparietal and occipital lobes in MRI scan, and corresponding bilateral visual field defects (Fig. 5B) . The third case with a CD4þ count of 22 cells/mL had a left-sided third and sixth nerve palsy. The association of these findings with the CD4þ count could not be analysed because of the few number of cases with the lesion.
Out of the 125 cases subjected to Schirmer's test and TBUT, 24 cases (19.2% of 125) with an average CD4þ count of 234.52 cells/mL had a positive Schirmer's test and a normal TBUT. Sixteen cases (12.8% of 125) with an average CD4þ count of 275 cells/mL had a subnormal TBUT and a normal Schirmer's test. Five cases (4% of 125) had both, a subnormal TBUT and a positive Schirmer's test. So a total of 45 cases (36% of 125) with a CD4þ range of 52-837 (average 256.96) cells/mL had a positive Schirmer's test and/or a subnormal TBUT (Fig. 1) . Out of these 45 cases, five cases (11.11%) had CD4þ count >500 cells/mL, 20 cases (44.44%) between 200 cells/mL and 499 cells/ mL and another 20 cases <200 cells/mL; 32 cases (25.6%) were in clinical stage A, four (3.2%) in stage B and the remaining nine (7.2%) in stage C. The observed difference in the frequency of these abnormal test results in various CD4þ categories of HIVpositive patients was not statistically significant (P ¼ 0.07). Even though the duration of ART in these cases was known, a detailed drug history was not available with regard to these patients. Hence the association of positive Schirmer's test or subnormal TBUT with ART could not be statistically analysed.
No significant difference was found between the mean CD4þ counts of the patients with ocular signs and those without ocular signs in the three individual groups based on CD4þ counts (P ¼ 0.39 in > 500, P ¼ 0.15 in 200-499, and P ¼ 0.17 in < 200 group) (Fig. 6) .
In summary, ocular findings in the 87 cases with decreasing order of prevalence were conjunctival microvasculopathy (9.66% of total, 35.63% of 87), anterior uveitis (7.79% of total, V 28.74% of 87), posterior uveitis (5.6% of total, 20.69% of 87), HIV retinopathy (3.74% of total, 13.79% of 87), molluscum contagiosum (1.87% of total, 6.90% of 87), and lastly neuro-ophthalmic manifestations (0.09% of total, 3.45% of 87). However, a large proportion of cases (36% of 125) had subnormal TBUT and/or Schirmer's test. The range of CD4þ counts at which these manifestations were seen has been illustrated in Fig. 7 .
Discussion
This study was carried out on subjects among whom 79.75% (256 cases) had the asymptomatic category A, 4.36% (14 cases) had category B, and only 15.89% (51 cases) had category C HIV infection. Contrary to this, a study done by Sujit Gharai et al consisted of 100 consecutive HIV cases, of whom only 17% had category A, 23% had category B, and the majority (60%) had category C HIV infection. 7 The ophthalmic manifestations in their study in decreasing order of frequency were CMV retinitis (20%), neuro-ophthalmic manifestations (12%), complicated cataract (6%), IRU in (5%), acute retinal necrosis (3%), choroiditis (2%), keratouveitis (1%), and corneal ulcer (1 %). Only 68% of these patients were on ART as compared to 85.05% cases in our study. It was 45% of cases in their study as compared to 27.10% (87 cases) in our study who had ophthalmic manifestations of HIV. Another study on South-Indian patients done by Sahu et al examined 19 cases of AIDS (group A) and their 6 relatives (group B) who were asymptomatic HIV-seropositive cases. 8 All cases in group A had ocular lesions whereas none of the cases in group B had the same. In our study too, we had 51 cases (15.89% of 321) fulfilling the CDC criteria of stage C of HIV infection and 43.14% (22 cases) of them had ocular manifestations. Only 24.07% (65 cases) of the remaining 270 cases, who were in stages A or B of HIV disease, had ocular lesions.
In another cross-sectional study done at a tertiary care centre in Western India, 112 HIV-positive patients, all with CD4þ count < 200 cells/mL, and all being on ART, were enrolled. 10 The prevalence of ocular manifestations in these cases was only nine out of 112 (8%). The ocular manifestations included HIV retinopathy (5%), IRU (3%), immune recovery vitreitis (3%), and CMV retinitis (2%). The presence of CMV retinitis in their study was comparable to that in our study (two out of 132 cases in the same CD4þ category), the difference not being statistically significant (P ¼ 0.86). Also the presence of HIV retinopathy of 5% in their study was comparable to that in our study (nine out of 132 cases in the same CD4þ category), the difference not being statistically significant (P ¼ 0.63). This study group had 100% of the cases with a CD4þ count <200 cells/mL as compared to only 41.12% in our study group. Only 8% (nine out of 112) of the cases in their study had ocular lesions as compared to 40.90% (54 out of 132) of the cases of the same CD4þ category in our study, the difference being statistically significant. This difference was prevalent because we had additional findings of molluscum contagiosum, conjunctival microvasculopathy, anterior uveitis, posterior uveitis, and neuro-ophthalmic lesions in our study.
Ours was a study group larger as compared to most other studies. Secondly the profile of our subjects was very different from those studies since 79.75% of our cases had asymptomatic category A HIV infection and were found to be HIV-positive on voluntary screening. The average CD4þ count of cases in our study is 276.54 cells/mL. We know that CMV retin-istis is known to occur mostly at CD4 counts of <50 cells/mL. We had only 39 cases with CD4þ counts <100 cells/mL in our study. Out of these 39 cases, only five cases had CD4þ count <50 cells/mL. This surely explains the low prevalence of CMV retinitis in our study. Since, the prevalence of CMV retinitis was low, we can explain why we did not have any case of IRU. Moreover, our cases had already been timely started on ART, antitubercular therapy (ATT), prophylactic antifungal medication, and prophylactic cotrimoxazole as per latest CDC guidelines. This could have cured most of the infective causes of uveitis like TB and toxoplasmosis leaving mostly inactive uveitic lesions when screened by the ophthalmologist during the study. All these factors have contributed to a varied profile of ophthalmic manifestations in our study as compared to the other studies.
Dry eye is a manifestation which has not been stated in most of the other studies. We do have a two year prospective, non-comparative study of 232 registered HIV patients done by Dhawan at a tertiary care centre, in which 93 (40.08%) patients were found to be of the category of mild dry eye on the basis of various tests. About 29 (12.5%) patients and 12 (5.17%) patients were of moderate and severe dry eye categories, respectively. So 57.75% cases in that study had dry eye. In our study, we found 36% (45 out of 125) with a subnormal TBUT and/or a positive Schirmer's test. However, the sensitivity and specificity of the Schirmer's test and TBUT is poor, especially when the reading has been taken only once and the findings are not supported by more specific tests.
14 Hence, further studies with more reliable tests and correlation with the drug history will have to done to find the actual prevalence of dry eye in HIV patients.
To summarise, in our study, CD4þ counts correlated with the prevalence of: (a) total ocular findings/lesions; (b) anterior uveitis; (c) posterior uveitis; and (d) HIV retinopathy, and did not correlate with (a) conjunctival microvasculopathy. Because the number of cases with the following lesions was very few, a reliable statistical analysis could not be done for (a) molluscum contagiosum, and (b) neuro-ophthalmological lesions. Most of the ocular lesions were seen in the CD4þ category of < 200 cells/mL. However, 13 cases (14.94% of the 87 cases with ocular findings) in this study had sight-threatening ocular lesions in spite of CD4þ count of >200 cells/mL.
We conclude that anterior uveitis, HIV retinopathy, and posterior uveitis had a significant association with the CD4þ count in our study and can therefore be considered as reliable markers of low CD4þ cell count in centres where the facility of CD4þ analysis does not exist. Secondly, there was a significant association of the overall occurrence of HIV-related ocular lesions with the CD4þ counts, most of the findings occurring at CD4þ counts < 200 cells/mL. Thirdly, there was no significant difference in the occurrence of ocular lesions between the symptomatic cases and the asymptomatic carriers of HIV. Hence, we can infer that even asymptomatic cases of HIV and also the cases with CD4þ cell count >200 cells/mL may be harbouring sight-threatening ocular lesions, and must be routinely screened for the same. 
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